Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

LON/0NEX stock hub

LON/0NEX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0NEXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.1B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0NEX

In the news

Latest news · LON/0NEX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-19.1

P25 -54.2P50 2.1P75 13.7

ROIC1.8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0NEX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

EUR

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	83,500
Employees Change	6%
Employees Change Percent	0.01
Enterprise value	EUR 9.3B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	FR0000184798
Last refreshed	2026-05-10
Market cap	EUR 2.1B
Price	EUR 15.09
Price currency	EUR
Rev Per Employee	61,592.55x
Sector	Healthcare
Sic	8051
Symbol	lon/0NEX
Website	https://www.emeis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.35%
EV Earnings	-35.64x
EV/EBIT	62.17x
EV/EBITDA	9.11x
EV/FCF	21.74x
EV/Sales	1.82x
FCF yield	20.24%
P/B ratio	1.72x
P/S ratio	0.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.94%
EBITDA Margin	14.14%
FCF margin	8.3%
Gross margin	13.78%
Gross Profit	EUR 708.4M
Gross Profit Growth	13.73%
Gross Profit Growth Q	28.44%
Gross Profit Growth3 Y	10.33%
Gross Profit Growth5 Y	6.1%
Net Income	EUR -260.3M
Net Income Growth Quarters	2%
Pretax Margin	-4.48%
Profit Margin	-5.06%
Profit Per Employee	EUR -3,118
ROA	0.83
Roa5y	0.41
ROCE	1.75
ROE	-19.1
Roe5y	-60.39
ROIC	1.82
Roic5y	0.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-43.31%
Cagr15y	-27.28%
Cagr1y	34.74%
Cagr3y	-55.11%
Cagr5y	-70.5%
Div CAGR10	0.03%
Div CAGR5	0%
EPS Growth Quarters	2
FCF Growth	-15.06%
FCF Growth3 Y	1.18%
FCF Growth5 Y	24.29%
OCF Growth	-39.41%
OCF Growth10 Y	-9.52%
OCF Growth3 Y	-5.46%
OCF Growth5 Y	2.69%
Revenue Growth	4.6x
Revenue Growth Q	4.29x
Revenue Growth Quarters	40x
Revenue Growth3 Y	2.78x
Revenue Growth5 Y	3.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.45
Assets	EUR 11B
Cash	EUR 294.1M
Current Assets	EUR 1.3B
Current Liabilities	EUR 2.2B
Debt	EUR 7.5B
Debt EBITDA	EUR 7.32
Debt Equity	EUR 6.13
Debt FCF	EUR 17.66
Equity	EUR 1.2B
Interest Coverage	0.5
Liabilities	EUR 9.8B
Long Term Assets	EUR 9.7B
Long Term Liabilities	EUR 7.6B
Net Cash	EUR -7.2B
Net Cash By Market Cap	EUR -343
Net Debt EBITDA	EUR 9.96
Net Debt Equity	EUR 5.89
Net Debt FCF	EUR 16.97
Tangible Book Value	EUR -1.4B
Tangible Book Value Per Share	EUR -8.38
WACC	4.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.64
Inventory Turnover	329.1
Net Working Capital	EUR -308.7M
Quick ratio	0.55
Working Capital	EUR -868.6M
Working Capital Turnover	EUR -5.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.37%
Dividend per share	EUR 0
Last Dividend	EUR 772

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.66%
1Y total return	34.71%
200-day SMA	13.72
3Y total return	-90.96%
50-day SMA	14.04
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.78%
All Time High	128,800
All Time High Change	-99.99%
All Time High Date	2020-02-20
All Time Low	4.48
All Time Low Change	237.06%
All Time Low Date	2024-12-17
ATR	0.48
Beta	0.55
Ch YTD	5.16
High	15.25
High52	16.15
High52 Date	2025-10-10
High52ch	-6.56%
Low	14.78
Low52	9.95
Low52 Date	2025-06-02
Low52ch	51.66%
Ma50ch	7.49%
Price vs 200-day SMA	10.01%
RSI	63.17
RSI Monthly	19.02
RSI Weekly	57.27
Sharpe ratio	0.68x
Sortino ratio	1.16
Total Return	-2.37%
Tr YTD	5.16
Tr15y	-99.16%
Tr1m	4.65%
Tr1w	4.94%
Tr3m	6.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 151.1M
Operating Income Growth	47.16
Operating Income Growth Q	355.5
Operating margin	2.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	125,071,762%
Net Borrowing	-747,387,378.2
Shares Insiders	0%
Shares Institutions	33.72%
Shares Qo Q	0%
Shares Yo Y	2.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 426.6M
Average Volume	23,565.95x
Bv Per Share	7.62
CAPEX	EUR -166.9M
Ch10y	-99.98
Ch15y	-99.96
Ch1m	4.65
Ch1w	4.94
Ch1y	34.71
Ch3m	6.04
Ch3y	-99.42
Ch5y	-99.99
Ch6m	17.89
Change	-1.28%
Change From Open	-0.59
Close	15.29
Days Gap	-0.72
Depreciation Amortization	570,920,913.9
Dollar Volume	5,574,547.8
Earnings Date	2026-09-23
EBIT	EUR 151.1M
EBITDA	EUR 727M
EPS	EUR -1.62
F Score	5
FCF	EUR 426.6M
FCF EV Yield	4.6x
Financing CF	-1,061,399,534
Fiscal Year End	December
Founded	1,989
Goodwill	1,130,596,415.9
Income Tax	EUR 30.1M
Investing CF	309,462,946
Is Primary Listing	0
Last Earnings Date	2026-04-08
Last Report Date	2025-12-31
Last Split Date	2024-03-22
Last Split Type	Reverse
Ma150	14
Ma150ch	7.76%
Ma20	14.22
Ma20ch	6.1%
Net CF	-158,443,856
Next Earnings Date	2026-09-23
Open	15.18
P FCF Ratio	4.94
P OCF Ratio	3.55
Position In Range	65.96
Ppne	6,396,909,330.8
Price Date	2026-05-08
Price EBITDA	EUR 2.9
Relative Volume	70.16x
Revenue	5,142,977,604x
Tax By Revenue	0.59x
Tr6m	17.89%
Volume	369,420
Z Score	0.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0NEX pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0NEX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0NEX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.7%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.4%

Negative means the company is buying back shares.

Technical

LON/0NEX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.2

Neutral momentum band

Price vs 200-day MA

+10.0%

50/200-day relationship not available

Beta (5Y)

0.55

Less volatile than the market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0NEX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0NEX stock rating?

lon/0NEX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0NEX analysis?

The full report lives at /stocks/lon/0NEX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0NEX?

The latest report frames lon/0NEX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0NEX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.